Seattle, WA -- (SBWire) -- 11/11/2019 --NEWS RELEASE CMI -- Degenerative disc disease is an age-related condition that happens when one or more discs between vertebrae of the spinal column deteriorates or worse breaks down. At the beginning, there may be numbness, weakness, and pain that radiates down the leg. Degenerative disc disease diagnosed through X-rays, physical inspection, or magnetic resonance imaging (MRI). This disease is commonly observed in geriatric population and a cause of low back pain and neck pain in adults. The common cases of back pain among patients occurs at the lower side of the back and is known as lower back pain. According to the American Association of Neurological Surgeons, in 2016, 75-85% of people in the U.S. experience some form of back pain in their life.

Furthermore, degenerative disc disease is treated by two common processes, depending upon the level of pain, including non-surgical procedure and spinal fusion procedure. The non-surgical treatments include medications, physical therapy and chiropractic care, while spinal fusion is a procedure used to surgically treat degenerative disc disease.

Download A Readymade Sample PDF Copy: https://www.coherentmarketinsights.com/insight/request-sample/1280

Market Dynamics
Recent advances in technology is expected to drive growth of the global degenerative disc disease treatment market in near future.
 
In the recent past, there have been a lot technological advancements in the field of healthcare, which is expected to drive growth of the global degenerative disc disease treatment market during the forecast period. For instance, in 2016, according to data published in Journal of Neurosurgery: Spine, the ProDisc technology has proven clinical efficacy in the U.S. Authors of the study found total disc replacement with ProDisc-C that the procedure is also cost-effective compared to spinal fusion and recorded an average of US $12,789 in savings, which is more effective than spinal fusion for single-level procedures.

Furthermore, manufacturers are involved in growth strategies such as acquisition, in order to strengthen the company's product portfolio. For instance, in October 2017, Centinel Spine acquired the ProDisc Total Disc Replacement portfolio from DePuy Synthes. This acquisition will provide a complete platform of proDisc technologies to Centinel Spine, which include, ProDisc-C, Discover, ProDisc-L, ProDisc-C Nova, ProDisc-C Vivo, and ProDisc-Oblique.  

Market Outlook
North America is expected to hold dominant position in the global degenerative disc disease treatment market over the forecast period

North America accounted for the largest share in the degenerative disc disease treatment market, followed by Europe in 2016. This is owing to increasing number of clinical trials in the U.S. for degenerative disc disease treatment. For instance, Centinel Spine is planning to commence clinical trials with the Nova, Vivo and Oblique technologies, currently sold outside of the U.S.

Get PDF Brochure of This Business Report: https://www.coherentmarketinsights.com/insight/request-pdf/1280

In December 2017, Camber Spine announced that this company has received U.S. Food and Drug Administration (FDA) clearance to market its SPIRA-C, Open Matrix Cervical Interbody device. This clearance marks Camber's second implant clearance in the SPIRA family of implant systems to be released in the U.S. market, indicated for use at one or two contiguous levels in the cervical spine, in skeletally mature patients who have had six weeks of non-operative treatment for the degenerative disk disease (DDD) with up to Grade 1 spondylolisthesis.

Furthermore, the Spinal Kinetics, Inc., the designer and manufacturer of the M6 artificial disc, announced in June 2017, that the total implantations of the company's M6-C Cervical and M6-L Lumbar discs have exceeded 50,000 throughout the international markets where the M6 is commercially available. This fact supports the growing demand of degenerative disc disease treatment market. 

Competitive Landscape
Key players operating in the global degenerative disc disease treatment market includes Medtronic Plc, Zimmer Biomet, Paradigm Spine, Globus Medical, Cousin Biotech, Ulrich Medical and SpineVision.

In-Depth Study of TOC & Direct Purchase Report @ https://www.coherentmarketinsights.com/insight/buy-now/1280

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.